스킵네비게이션

Enterprise Together with KSC

Company Overview
Real-time analysis of diseases caused by color, size, distribution, shape, inclusion body, infection, etc. of blood cells(red blood cells, white blood cells, platelets) through our built-in artificial intelligence algorithms application

Sectors

  • AI, Bio Medical

Project Summary

  • Clinical Decision Support System Software for analyzing microscope images

Business Model

  • Revenue modelApplication fees
  • Key Customer Hospitals, Labs(1st target)
Major Performance

  • Sales

    • 2019-0
    • 2021-$26,000

  • Investment

    • Non-disclosure

  • Employees

    • 2019-4
    • 2020-21
    • 2021 1H-4

  • Patent

    • Korea 4 / PCT 1
Overseas Expansion

Stage

Preparing for overseas expansion

Status

POC

Short-term goals in three years
  • ① Prototype development
  • ② Preparing for validation test
  • ③ Apply for TIPS
  • ④ Diagnostics medical device market authorization submissions
  • ⑤ Overseas joint research cooperation
Target Country
Israel
Date of Establishment
Dec 05, 2018
  • CEO
    Hyemin Lee, Jungmin Lee
  • Founder’s Background
    • Hyemin Lee - Artix, co-founder(2018~present)
    • Sungkyunkwan University, Adjunct Professor(2018~present)
    • Seoul National University, Ph.D. /
    • Korea Advanced Institute of Science & Technology, M.S. /
    • School of the Art Institute of Chicago, B.F.A.
    • Jungmin Lee - Artix, co-founder(2018~present)
    • Korea University Medical Center, Diagnostic Laboratory Medicine, Resident Physician
    • Chung-Ang University College of Medicine, M.D.
    • Boston College, Economics, B.A.
목록